Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 01-Mar-16 4:09 PM View:  | Wyand Michael Chief Technical Officer | Epirus Biopharmaceuticals, ... (ZLCS) | 27-Feb-16 | Option Exercise | 3,652 | -- | -- | 12% 30.39K to 34.04K | |
| 01-Mar-16 4:10 PM View: | Munshi Amit Chief Executive Officer Director | Epirus Biopharmaceuticals, ... (ZLCS) | 27-Feb-16 | Option Exercise | 11,406 | -- | -- | 7% 169.98K to 181.39K | |
| 01-Mar-16 4:09 PM View: | Wyand Michael Chief Technical Officer | Epirus Biopharmaceuticals, ... (ZLCS) | 27-Feb-16 | Payment of Exercise | 1,379 | $2.80 | $3,861.20 | (4%) 34.04K to 32.66K | |
| 01-Mar-16 4:11 PM View: | Ticktin Robert General Counsel | Epirus Biopharmaceuticals, ... (ZLCS) | 27-Feb-16 | Option Exercise | 3,083 | -- | -- | 103% 3.0K to 6.08K | |
| 01-Mar-16 4:11 PM View: | Shea Thomas A. Chief Financial Officer | Epirus Biopharmaceuticals, ... (ZLCS) | 27-Feb-16 | Option Exercise | 4,117 | -- | -- | 14% 28.93K to 33.04K | |
| 01-Mar-16 4:10 PM View: | Munshi Amit Chief Executive Officer Director | Epirus Biopharmaceuticals, ... (ZLCS) | 27-Feb-16 | Payment of Exercise | 4,305 | $2.80 | $12,054.00 | (2%) 181.39K to 177.08K | |
| 01-Mar-16 4:11 PM View: | Shea Thomas A. Chief Financial Officer | Epirus Biopharmaceuticals, ... (ZLCS) | 27-Feb-16 | Payment of Exercise | 1,554 | $2.80 | $4,351.20 | (5%) 33.04K to 31.49K | |
| 22-Dec-15 8:00 AM View: | Ticktin Robert General Counsel | Epirus Biopharmaceuticals, ... (ZLCS) | 21-Dec-15 | Purchase | 3,000 | $3.72 | $11,161.50 | 100% 0 to 3.0K | |
| 21-Dec-15 8:48 AM View: | Vincent Aurentz Chief Business Officer | Epirus Biopharmaceuticals, ... (ZLCS) | 17-Dec-15 | Purchase | 2,200 | $3.43 | $7,546.00 | 79% 2.8K to 5.0K | |
| 17-Dec-15 8:01 AM View: | Munshi Amit Chief Executive Officer Director | Epirus Biopharmaceuticals, ... (ZLCS) | 16-Dec-15 | Purchase | 8,270 | $2.80 | $23,156.00 | 5% 161.71K to 169.98K | |
| 16-Dec-15 8:00 AM View: | Munshi Amit Chief Executive Officer Director | Epirus Biopharmaceuticals, ... (ZLCS) | 15-Dec-15 | Purchase | 8,069 | $2.87 | $23,158.00 | 5% 153.64K to 161.71K | |
| 10-Dec-15 8:00 AM View: | Munshi Amit Chief Executive Officer Director | Epirus Biopharmaceuticals, ... (ZLCS) | 09-Dec-15 | Purchase | 13,190 | $4.07 | $53,683.30 | 9% 140.45K to 153.64K | |
| 11-Dec-15 8:00 AM View: | Vincent Aurentz Chief Business Officer | Epirus Biopharmaceuticals, ... (ZLCS) | 09-Dec-15 | Purchase | 2,800 | $3.85 | $10,780.00 | 100% 0 to 2.8K | |
| 03-Nov-15 4:37 PM View: | Shea Thomas A. Chief Financial Officer | Epirus Biopharmaceuticals, ... (ZLCS) | 03-Nov-15 | Option Exercise | 28,926 | $1.30 | $37,603.80 | 100% 0 to 28.93K | |
| 22-Sep-15 8:00 AM View: | Munshi Amit Chief Executive Officer Director | Epirus Biopharmaceuticals, ... (ZLCS) | 21-Sep-15 | Purchase | 10,000 | $6.19 | $61,900.00 | 8% 130.45K to 140.45K | |
| 21-Sep-15 11:52 AM View: | Munshi Amit Chief Executive Officer Director | Epirus Biopharmaceuticals, ... (ZLCS) | 18-Sep-15 | Purchase | 10,000 | $5.99 | $59,860.00 | 8% 120.45K to 130.45K | |
| 14-Sep-15 4:30 PM View: | Wyand Michael Chief Technical Officer | Epirus Biopharmaceuticals, ... (ZLCS) | 14-Sep-15 | Option Exercise | 8,747 | $1.00 | $8,747.00 | 40% 21.64K to 30.39K | |
| 06-Jul-15 4:32 PM View: | Munshi Amit Chief Executive Officer Director | Epirus Biopharmaceuticals, ... (ZLCS) | 02-Jul-15 | Option Exercise | 51,200 | $1.00 | $51,200.00 | 74% 69.25K to 120.45K | |
| 09-Feb-15 12:09 PM View: | Montreux Equity Partners Iv... 10% Owner | Epirus Biopharmaceuticals, ... (ZLCS) | 06-Feb-15 | Private Sale | 100,000 | $5.01 | $500,930.00 | (5%) 2.04M to 1.94M | |
| 09-Feb-15 12:09 PM View: | Montreux Equity Partners Iv... 10% Owner | Epirus Biopharmaceuticals, ... (ZLCS) | 05-Feb-15 | Private Sale | 67,316 | $4.97 | $334,843.00 | (3%) 2.11M to 2.04M | |
| 06-Feb-15 2:28 PM View: | Rocklage Scott M Director 10% Owner | Epirus Biopharmaceuticals, ... (ZLCS) | 04-Feb-15 | Purchase | 400,000 | $5.00 | $2,000,000.00 | 18% 2.21M to 2.61M | |
| 05-Feb-15 12:20 PM View: | Montreux Equity Partners Iv... 10% Owner | Epirus Biopharmaceuticals, ... (ZLCS) | 04-Feb-15 | Private Sale | 5,684 | $4.95 | $28,138.60 | (< 1%) 2.12M to 2.11M | |
| 06-Feb-15 3:48 PM View: | 5am Partners Iii, LLC 10% Owner | Epirus Biopharmaceuticals, ... (ZLCS) | 04-Feb-15 | Purchase Duplicate | 400,000 | $5.00 | $2,000,000.00 | 18% 2.21M to 2.61M | |
| 05-Feb-15 12:20 PM View: | Montreux Equity Partners Iv... 10% Owner | Epirus Biopharmaceuticals, ... (ZLCS) | 03-Feb-15 | Private Sale | 47,000 | $4.99 | $234,431.00 | (2%) 2.16M to 2.12M | |
| 28-Jan-15 4:05 PM View: | Montreux Equity Partners Iv... 10% Owner | Epirus Biopharmaceuticals, ... (ZLCS) | 26-Jan-15 | Private Sale | 38,516 | $6.47 | $249,102.00 | (2%) 2.2M to 2.16M | |
| 26-Jan-15 1:46 PM View: | Montreux Equity Partners Iv... 10% Owner | Epirus Biopharmaceuticals, ... (ZLCS) | 23-Jan-15 | Private Sale | 8,400 | $6.27 | $52,699.10 | (< 1%) 2.21M to 2.2M | |
| 26-Jan-15 1:46 PM View: | Montreux Equity Partners Iv... 10% Owner | Epirus Biopharmaceuticals, ... (ZLCS) | 22-Jan-15 | Private Sale | 14,130 | $6.30 | $88,979.40 | (< 1%) 2.22M to 2.21M | |
| 17-Jul-14 8:49 PM View: | Wyand Michael See Remarks | Epirus Biopharmaceuticals, ... (ZLCS) | 15-Jul-14 | Grant | 21,641 | -- | -- | 100% 0 to 21.64K | |
| 17-Jul-14 9:18 PM View: | Corrigan Mark Director | Epirus Biopharmaceuticals, ... (ZLCS) | 15-Jul-14 | Payment of Exercise | 14,597 | $11.80 | $172,245.00 | (40%) 36.46K to 21.86K | |
| 17-Jul-14 9:10 PM View: | Munshi Amit Chief Executive Officer Director | Epirus Biopharmaceuticals, ... (ZLCS) | 15-Jul-14 | Grant | 69,253 | -- | -- | 100% 0 to 69.25K | |
| 17-Jul-14 5:09 PM View: | Tpg Group Holdings (sbs) Ad... 10% Owner | Epirus Biopharmaceuticals, ... (ZLCS) | 15-Jul-14 | Acquisition (other) | 22,239,200 | -- | -- | 100% 0 to 22.24M | |
| 12-Feb-14 4:07 PM View: | Renz Justin A EVP, CFO & Treasurer | Epirus Biopharmaceuticals, ... (ZLCS) | 10-Feb-14 | Grant | 250,000 | -- | -- | 100% 0 to 250.0K | |
| 12-Feb-14 4:03 PM View: | Corrigan Mark President & CEO Director | Epirus Biopharmaceuticals, ... (ZLCS) | 10-Feb-14 | Grant | 250,000 | -- | -- | 218% 114.57K to 364.57K | |
| 17-Jan-14 4:04 PM View: | Corrigan Mark President & CEO Director | Epirus Biopharmaceuticals, ... (ZLCS) | 15-Jan-14 | Payment of Exercise | 18,079 | $1.66 | $30,011.10 | (14%) 132.65K to 114.57K | 31% |
| 07-Jan-14 4:16 PM View: | Corrigan Mark President & CEO Director | Epirus Biopharmaceuticals, ... (ZLCS) | 03-Jan-14 | Payment of Exercise | 8,035 | $1.22 | $9,802.70 | (6%) 140.68K to 132.65K | 7% |
| 17-Jan-13 4:10 PM View: | Corrigan Mark President & CEO Director | Epirus Biopharmaceuticals, ... (ZLCS) | 15-Jan-13 | Market Sale | 112,850 | $0.77 | $86,894.50 | (12%) 956.94K to 844.09K | 75% |
| 07-Jan-13 1:03 PM View: | Corrigan Mark President & CEO Director | Epirus Biopharmaceuticals, ... (ZLCS) | 03-Jan-13 | Grant | 250,000 | -- | -- | 35% 706.94K to 956.94K | |
| 29-Feb-12 4:08 PM View: | Gallen Christopher C. EVP Research & Development | Epirus Biopharmaceuticals, ... (ZLCS) | 29-Feb-12 | Grant | 350,000 | -- | -- | 23% 1.49M to 1.84M | |
| 31-Jan-12 4:11 PM View: | Cole Jason SVP & General Counsel | Epirus Biopharmaceuticals, ... (ZLCS) | 27-Jan-12 | Market Sale (Planned) | 2,420 | $1.09 | $2,637.80 | (14%) 17.51K to 15.09K | 82% |
| 19-Jan-12 4:14 PM View: | Corrigan Mark President & CEO Director | Epirus Biopharmaceuticals, ... (ZLCS) | 17-Jan-12 | Market Sale (Planned) | 68,105 | $1.14 | $77,639.70 | (9%) 775.04K to 706.94K | 83% |
| 28-Oct-11 12:53 PM View: | Evnin Luke 10% Owner | Epirus Biopharmaceuticals, ... (ZLCS) | 27-Oct-11 | Market Sale Duplicate | 738,807 | $1.03 | $760,971.00 | (6%) 11.87M to 11.13M | 81% |
| 28-Oct-11 12:51 PM View: | Mpm Bioventures III LLC 10% Owner | Epirus Biopharmaceuticals, ... (ZLCS) | 27-Oct-11 | Market Sale | 738,807 | $1.03 | $760,971.00 | (6%) 11.87M to 11.13M | 81% |
| 27-Oct-11 3:22 PM View: | Mpm Bioventures III LLC 10% Owner | Epirus Biopharmaceuticals, ... (ZLCS) | 26-Oct-11 | Market Sale | 78,000 | $1.02 | $79,560.00 | (< 1%) 23.9M to 23.82M | 81% |
| 27-Oct-11 3:24 PM View: | Evnin Luke 10% Owner | Epirus Biopharmaceuticals, ... (ZLCS) | 26-Oct-11 | Market Sale Duplicate | 78,000 | $1.02 | $79,560.00 | (< 1%) 23.9M to 23.82M | 81% |
| 27-Oct-11 3:22 PM View: | Mpm Bioventures III LLC 10% Owner | Epirus Biopharmaceuticals, ... (ZLCS) | 25-Oct-11 | Market Sale | 203,200 | $1.02 | $207,264.00 | (< 1%) 24.1M to 23.9M | 81% |
| 27-Oct-11 3:24 PM View: | Evnin Luke 10% Owner | Epirus Biopharmaceuticals, ... (ZLCS) | 25-Oct-11 | Market Sale Duplicate | 203,200 | $1.02 | $207,264.00 | (< 1%) 24.1M to 23.9M | 81% |
| 25-Oct-11 2:11 PM View: | Evnin Luke 10% Owner | Epirus Biopharmaceuticals, ... (ZLCS) | 24-Oct-11 | Market Sale | 252,000 | $1.03 | $259,560.00 | (1%) 24.81M to 24.56M | 81% |
| 25-Oct-11 2:44 PM View: | Mpm Bioventures III LLC 10% Owner | Epirus Biopharmaceuticals, ... (ZLCS) | 24-Oct-11 | Market Sale Duplicate | 252,000 | $1.03 | $259,560.00 | (1%) 24.81M to 24.56M | 81% |
| 25-Oct-11 2:44 PM View: | Mpm Bioventures III LLC 10% Owner | Epirus Biopharmaceuticals, ... (ZLCS) | 21-Oct-11 | Market Sale Duplicate | 70,100 | $1.02 | $71,502.00 | (< 1%) 24.88M to 24.81M | 81% |
| 25-Oct-11 2:11 PM View: | Evnin Luke 10% Owner | Epirus Biopharmaceuticals, ... (ZLCS) | 21-Oct-11 | Market Sale | 70,100 | $1.02 | $71,502.00 | (< 1%) 24.88M to 24.81M | 81% |
